{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:58:44Z","timestamp":1771549124323,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cpcardiol.2023.102061","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T11:01:17Z","timestamp":1693047677000},"page":"102061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"PA","title":["Medication Adherence With Polypill in Cardiovascular Disease and High-Risk Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Involving 7364 Participants"],"prefix":"10.1016","volume":"49","author":[{"given":"Masoumeh","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Bostan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golsa","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaal","family":"Alavi Tabatabaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Rafiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheleh","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.102061_bib0001","series-title":"Global atlas on cardiovascular disease prevention and control","author":"Mendis","year":"2011"},{"issue":"25","key":"10.1016\/j.cpcardiol.2023.102061_bib0002","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2023.102061_bib0003","doi-asserted-by":"crossref","first-page":"e52145","DOI":"10.1371\/journal.pone.0052145","article-title":"The efficacy and tolerability of \u201cpolypills\u201d: meta-analysis of randomised controlled trials","volume":"7","author":"Elley","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.102061_bib0004","first-page":"e34134","article-title":"Effect of the polypill on adherence and prevention of cardiovascular diseases in patients with or at high risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"15","author":"Memon","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102061_bib0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/pharmaceutics12020190","article-title":"Does the polypill improve patient adherence compared to its individual formulations? a systematic review","volume":"12","author":"Baumgartner","year":"2020","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.cpcardiol.2023.102061_bib0006","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1815359","article-title":"Polypill for cardiovascular disease prevention in an underserved population","volume":"381","author":"Mu\u00f1oz","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.102061_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002498","article-title":"Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study","volume":"3","author":"Virdee","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.102061_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/1467-8551.00375","article-title":"Towards a methodology for developing evidence-informed management knowledge by means of systematic review","volume":"14","author":"Tranfield","year":"2003","journal-title":"Br J Manage"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.102061_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40273-014-0205-3","article-title":"Bidirectional citation searching to completion: an exploration of literature searching methods","volume":"33","author":"Hinde","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"7650","key":"10.1016\/j.cpcardiol.2023.102061_bib0011","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0012","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.102061_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0014","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K. Dplyr: A grammar of data manipulation (R package version 0.7. 6)[Computer software]. 2018."},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.102061_bib0015","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.102061_bib0016","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.ki.5002432","article-title":"Measures of effect: relative risks, odds ratios, risk difference, and \u201cnumber needed to treat","volume":"72","author":"Tripepi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0017","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2008"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102061_bib0018","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1094428106291059","article-title":"Estimating effect sizes from pretest-posttest-control group designs","volume":"11","author":"Morris","year":"2008","journal-title":"Org Res Methods"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0019","unstructured":"Wilson DB. Practical meta-analysis effect size calculator [Computer software]. Available at: https:\/\/www.campbellcollaboration.org\/resources\/effect_size_input.php,consultado.em. 2001;22(12):2018. Accessed August 16, 2023"},{"issue":"6977","key":"10.1016\/j.cpcardiol.2023.102061_bib0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.102061_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101735","article-title":"Polypill therapy in cardiovascular disease: a meta-analysis of randomized controlled trials","volume":"48","author":"Hennawi","year":"2023","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.102061_bib0022","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/jch.14075","article-title":"The feasibility of polypill for cardiovascular disease prevention in Asian Population","volume":"23","author":"Sukonthasarn","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pcad.2022.01.005","article-title":"Association of Polypill therapy with cardiovascular outcomes, mortality, and adherence: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Rao","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.102061_bib0024","article-title":"Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases","volume":"3","author":"Bahiru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.102061_bib0025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pcad.2013.02.001","article-title":"Adherence to cardiovascular medications: lessons learned and future directions","volume":"55","author":"Kronish","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.102061_bib0026","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102061_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cpcardiol.2023.102061_bib0028","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1111\/jan.14528","article-title":"Using risk and odds ratios to assess effect size for meta-analysis outcome measures","volume":"76","author":"Alavi","year":"2020","journal-title":"J Adv Nurs"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.102061_bib0029","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2004.058230","article-title":"Understanding systematic reviews and meta-analysis","volume":"90","author":"Akobeng","year":"2005","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102061_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2013.1113","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"Clin Med Res"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102061_bib0031","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/jwh.2012.3972","article-title":"Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines","volume":"23","author":"Manteuffel","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102061_bib0032","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ehjcvp\/pvx013","article-title":"Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study","volume":"4","author":"Fr\u00f6hlich","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.102061_bib0033","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/jch.14695","article-title":"Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: a systematic review, and network meta-analysis","volume":"25","author":"Hu","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"20","key":"10.1016\/j.cpcardiol.2023.102061_bib0034","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/CIRCULATIONAHA.109.873232","article-title":"The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions","volume":"122","author":"Lonn","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0035","unstructured":"Lisinopril vs Ramipril comparison-drugs.com. Accessed August 16, 2023. Available at: https:\/\/www.drugs.com\/compare\/lisinopril-vs-ramipril"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.102061_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"issue":"10285","key":"10.1016\/j.cpcardiol.2023.102061_bib0037","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2023.102061_bib0038","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2022.04.085","article-title":"Polypill for cardiovascular disease prevention: systematic review and meta-analysis of randomized controlled trials","volume":"360","author":"Mohamed","year":"2022","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.102061_bib0039","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13643-019-1014-8","article-title":"Medication adherence influencing factors-an (updated) overview of systematic reviews","volume":"8","author":"Gast","year":"2019","journal-title":"Syst Rev"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623004784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623004784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:27:01Z","timestamp":1758940021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623004784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0146280623004784"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102061","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication Adherence With Polypill in Cardiovascular Disease and High-Risk Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Involving 7364 Participants","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"102061"}}